Solventum (SOLV) Stock Forecast & Price Target

$74.67 +0.25 (+0.34%)

As of 01:58 PM Eastern

Compare

Solventum - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Moderate Buy

Based on 14 Analyst Ratings

Sell
1

Hold
5

Buy
8

Based on 14 Wall Street analysts who have issued ratings for Solventum in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 14 analysts, 1 has given a sell rating, 5 have given a hold rating, and 8 have given a buy rating for SOLV.

Consensus Price Target

$84.25
12.83% Upside

According to the 14 analysts' twelve-month price targets for Solventum, the average price target is $84.25. The highest price target for SOLV is $103.00, while the lowest price target for SOLV is $50.00. The average price target represents a forecasted upside of 12.83% from the current price of $74.67.

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Get the Latest News and Ratings for SOLV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Solventum and its competitors.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SOLV Analyst Ratings Over Time

Type	Current Forecast 5/15/25 to 5/15/26	1 Month Ago 4/15/25 to 4/15/26	3 Months Ago 2/14/25 to 2/14/26	1 Year Ago 5/15/24 to 5/15/25
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	8 Buy rating(s)	7 Buy rating(s)	7 Buy rating(s)	1 Buy rating(s)
Hold	5 Hold rating(s)	5 Hold rating(s)	6 Hold rating(s)	8 Hold rating(s)
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$84.25	$90.64	$90.83	$79.00
Forecasted Upside	12.83% Upside	31.23% Upside	20.16% Upside	8.32% Upside
Consensus Rating	Moderate Buy	Hold	Hold	Hold

SOLV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SOLV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Solventum Stock vs. The Competition

Type	Solventum	Medical Companies	Broader Market
Consensus Rating Score	2.46	2.30	2.52
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	12.05% Upside	1,807.06% Upside	16.79% Upside
News Sentiment Rating	Neutral News See Recent SOLV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export

Date	Brokerage	Analyst	Action	Rating	Price Target	Report Date Upside/Downside
5/15/2026	Wedbush 5 of 5 stars	Michael Piccolo Not Rated	Initiated Coverage	Outperform	$94.00	+26.35%
5/14/2026	UBS Group 4 of 5 stars	Kevin Caliendo 2 of 5 stars	Downgrade	Buy ➝ Neutral	$50.00	-32.82%
5/6/2026	Stifel Nicolaus 4 of 5 stars	Rick Wise 2 of 5 stars	Lower Target	Buy	$105.00 ➝ $90.00	+27.34%
5/6/2026	KeyCorp Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Brett Fishbin Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Overweight	$92.00 ➝ $93.00	+34.61%
5/6/2026	Wells Fargo & Company Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Larry Biegelsen Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Equal Weight	$83.00 ➝ $70.00	-0.81%
5/6/2026	BTIG Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Ryan Zimmerman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Reiterated Rating	Buy	$89.00	+28.82%
4/17/2026	Piper Sandler Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jason Bednar Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Lower Target	Overweight	$98.00 ➝ $92.00	+33.69%
3/24/2026	Rothschild & Co Redburn Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Jackson Philips Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Sell	$60.00	-8.73%
1/27/2026	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Reiterated Rating	Hold (C)
1/20/2026	Mizuho Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Steven Valiquette Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Set Target	Neutral ➝ Outperform	$85.00 ➝ $100.00	+25.64%
Iran's New Leader Just Said Something That Should Terrify Every American (Ad) Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of the world's oil passing through that corridor, crude has already crossed $100 per barrel. History shows gold surged 571% during the 1973 oil crisis and 425% in 1979. Today, the U.S. holds 8,133 tonnes of gold valued on the books at $42.22 per ounce - while gold trades above $5,000. American Alternative Assets has released The Great Gold Reset report detailing what this gap could mean for investors. Claim your free copy of The Great Gold Reset report today
12/1/2025	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating		Downgrade	Strong-Buy ➝ Hold
9/11/2025	Jefferies Financial Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Michael Toomey Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Hold	$80.00	+12.29%
7/15/2025	Morgan Stanley Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Patrick Wood Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Equal Weight ➝ Overweight	$80.00 ➝ $103.00	+39.04%
7/1/2025	Argus Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	John Staszak Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Upgrade	Hold ➝ Buy	$90.00	+18.72%
3/3/2025	The Goldman Sachs Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	David Roman Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Sell	$63.00 ➝ $71.00	-9.76%
2/26/2025	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Travis Steed Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Boost Target	Neutral	$80.00 ➝ $85.00	+1.51%
9/26/2024	Wolfe Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Chris Senyek Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating	Initiated Coverage	Peer Perform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Friday at 01:58 PM ET.

SOLV Forecast - Frequently Asked Questions

According to the research reports of 14 Wall Street equities research analysts, the average twelve-month stock price forecast for Solventum is $84.25, with a high forecast of $103.00 and a low forecast of $50.00.

14 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Solventum in the last year. There is currently 1 sell rating, 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "moderate buy" SOLV shares.

According to analysts, Solventum's stock has a predicted upside of 12.83% based on their 12-month stock forecasts.

Over the previous 90 days, Solventum's stock had 1 upgrade and 1 downgrade by analysts.

Solventum has been rated by research analysts at BTIG Research, KeyCorp, Piper Sandler, Rothschild & Co Redburn, Stifel Nicolaus, UBS Group, Wedbush, and Wells Fargo & Company in the past 90 days.

Analysts like Solventum more than other "medical" companies. The consensus rating for Solventum is Moderate Buy while the average consensus rating for "medical" companies is Hold. Learn more on how SOLV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Solventum Recommendations

This page (NYSE:SOLV) was last updated on 5/15/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solventum (SOLV) Stock Forecast & Price Target

Solventum - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

SOLV Analyst Ratings Over Time

SOLV Analyst Recommendations By Month

SOLV Price Targets by Month

Solventum Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

SOLV Forecast - Frequently Asked Questions

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Solventum Recommendations

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Solventum (SOLV) Stock Forecast & Price Target

Solventum - Analysts' Recommendations and Stock Price Forecast (2026)

Consensus Rating

Consensus Price Target

SOLV Analyst Ratings Over Time

SOLV Analyst Recommendations By Month

SOLV Price Targets by Month

Solventum Stock vs. The Competition

Recent Analyst Forecasts and Stock Ratings

SOLV Forecast - Frequently Asked Questions

What is Solventum's forecast for 2026?

Should I buy or sell Solventum stock right now?

Does Solventum's stock price have much upside?

Has Solventum been upgraded or downgraded by Wall Street analysts recently?

What analysts cover Solventum?

Do Wall Street analysts like Solventum more than its competitors?

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Brokerages With Solventum Recommendations

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools